Bank Julius Baer & Co. Ltd Zurich Purchases 1,629 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Bank Julius Baer & Co. Ltd Zurich grew its position in Mettler-Toledo International Inc. (NYSE:MTD) by 14.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,070 shares of the medical instruments supplier’s stock after acquiring an additional 1,629 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich owned 0.06% of Mettler-Toledo International worth $16,103,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Huntington National Bank grew its position in Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after acquiring an additional 9 shares during the last quarter. Townsquare Capital LLC increased its holdings in shares of Mettler-Toledo International by 2.0% in the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after purchasing an additional 9 shares during the period. M3 Advisory Group LLC increased its holdings in shares of Mettler-Toledo International by 5.8% in the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after purchasing an additional 9 shares during the period. Apollon Wealth Management LLC grew its holdings in Mettler-Toledo International by 2.5% during the fourth quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after acquiring an additional 9 shares during the period. Finally, Steward Partners Investment Advisory LLC grew its holdings in Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock worth $374,000 after acquiring an additional 9 shares during the period. Institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MTD has been the topic of a number of recent analyst reports. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Citigroup cut their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Robert W. Baird upped their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $1,380.50.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,292.69 on Friday. Mettler-Toledo International Inc. has a 12 month low of $1,142.91 and a 12 month high of $1,546.93. The stock has a market cap of $27.04 billion, a price-to-earnings ratio of 31.89, a PEG ratio of 3.30 and a beta of 1.15. The stock’s 50 day moving average price is $1,293.77 and its 200 day moving average price is $1,324.10.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, sell-side analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.